NCT03783000已完成1 期
Investigation of Pharmacokinetics and Absolute Oral Bioavailability of BI 425809 Administered as an Oral Dose With an Intravenous Microtracer Dose of [C-14]-BI 425809 in Healthy Male Volunteers
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 6
- 试验地点
- 1
- 主要终点
- AUC0-∞ (area under the concentration-time curve of the analyte over the time interval from 0 to infinity)
研究概览
简要总结
The primary objective of this trial is to investigate the absolute oral bioavailability of BI 425809 administered as tablet (Test, T) compared to [C-14]-BI 425809 administered as intravenous microtracer (Reference, R).
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Healthy male subjects according to the assessment of the investigator, based on a complete medical history including a physical examination, vital signs (Blood Pressure (BP), Pulse Rate (PR)), 12-lead Electrocardiogram (ECG), and clinical laboratory tests
- •Age of 18 to 65 years (incl.)
- •Body mass index (BMI) of 18.5 to 29.9 kg/m2 (incl.)
- •Signed and dated written informed consent prior to admission to the study in accordance with Good Clinical Practice (GCP) and local legislation
- •Subjects who are sexually active must use, with their partner, highly effective contraception from the time of administration of trial medication until 4 months after administration of trial medication. Adequate methods are:
- •Condoms plus use of hormonal contraception by the female partner that started at least 2 months prior to administration of trial medication (e.g., implants, injectables, combined oral or vaginal contraceptives, intrauterine device) or
- •Condoms plus surgical sterilization (vasectomy at least 1 year prior to enrolment) or
- •Condoms plus surgically sterilised partner (including hysterectomy) or
- •Condoms plus intrauterine device or
- •Condoms plus partner of non-childbearing potential (including homosexual men) Subjects are required to use condoms to prevent unintended exposure of the partner to the study drug via seminal fluid.
- •Alternatively, true abstinence is acceptable when it is in line with the subject's preferred and usual lifestyle. If a subject is usually not sexually active but becomes active, with their partner, they must comply with the contraceptive requirements detailed above.
排除标准
- •Any finding in the medical examination (including Blood Pressure (BP), Pulse Rate (PR) or Electrocardiogram (ECG)) is deviating from normal and judged as clinically relevant by the investigator
- •Repeated measurement of systolic blood pressure outside the range of 90 to 139 mmHg, diastolic blood pressure outside the range of 45 to 89 mmHg, or pulse rate outside the range of 40 to 100 bpm
- •Any laboratory value outside the reference range that the investigator considers to be of clinical relevance
- •Any evidence of a concomitant disease judged as clinically relevant by the investigator
- •Clinically significant gastrointestinal, hepatic, renal, respiratory (including but not limited to interstitial lung disease), cardiovascular, metabolic, immunological or hormonal disorders
- •Further exclusion criteria apply
研究组 & 干预措施
All subjects
Experimental
Treatment T followed by Treatment R
干预措施: BI 425809 mixed with [C-14]-BI 425809 (Drug)
All subjects
Experimental
Treatment T followed by Treatment R
干预措施: BI 425809 (Drug)
结局指标
主要结局
AUC0-∞ (area under the concentration-time curve of the analyte over the time interval from 0 to infinity)
时间窗: Up to 168 hours
次要结局
- Cmax (maximum measured concentration of the analyte in plasma)(Up to 168 hours)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Study in Healthy Men to Test How BI 1291583 is Taken up by the BodyHealthyNCT06166992Boehringer Ingelheim14
已完成
1 期
A Study in Healthy Men to Test How BI 1015550 is Taken up and Handled by the BodyHealthyNCT05707403Boehringer Ingelheim8
已完成
1 期
This Study in Healthy Men and Women Tests How the Body Takes up BI 409306HealthyNCT03505151Boehringer Ingelheim9
已完成
1 期
A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1358894 in the BloodHealthyNCT03843151Boehringer Ingelheim16
已完成
1 期
Bioavailability of BI 44370 TA Drinking Solution or Tablets With and Without a High Fat Meal in Healthy Male and Female VolunteersHealthyNCT02215746Boehringer Ingelheim12